Thanks NZT good find. For me this adds another 'indicator'. Elanco being involved in trial design speaks volumes, and supplying a sizeable ($$ wise) amount of product just supports it further. I knew they had supplied the MPL but figured it wouldn't be more than a few thousand worth, never saw this costing.
Added more PAA to the collection yesterday. I can't see Elanco being this involved, only to walk away from good results that they helped set the parameters for.
Ann: Appendix 4C and Quarterly Update, page-168
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
17.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $85.12M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 17.0¢ | $141.2K | 801.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 537419 | 17.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.0¢ | 140000 | 3 |
View Market Depth
| Last trade - 16.10pm 06/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |